ZA200900492B - Human protein tyrosine phosphatase inhibitors and methods of use - Google Patents
Human protein tyrosine phosphatase inhibitors and methods of useInfo
- Publication number
- ZA200900492B ZA200900492B ZA200900492A ZA200900492A ZA200900492B ZA 200900492 B ZA200900492 B ZA 200900492B ZA 200900492 A ZA200900492 A ZA 200900492A ZA 200900492 A ZA200900492 A ZA 200900492A ZA 200900492 B ZA200900492 B ZA 200900492B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- protein tyrosine
- human protein
- tyrosine phosphatase
- phosphatase inhibitors
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81673106P | 2006-06-27 | 2006-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900492B true ZA200900492B (en) | 2010-06-30 |
Family
ID=40977658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900492A ZA200900492B (en) | 2006-06-27 | 2009-01-21 | Human protein tyrosine phosphatase inhibitors and methods of use |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101506180B (en) |
ZA (1) | ZA200900492B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SMP200800060B (en) | 2006-04-07 | 2009-07-14 | Procter & Gamble | Antibodies that bind the human protein tyrosine phosphatase beta (hptbeta) and their uses |
US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
KR101823924B1 (en) * | 2010-10-07 | 2018-01-31 | 에르피오 세러퓨틱스 인코포레이티드 | Compositions and methods for treating ocular edema, neovascularization and related diseases |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60023920T2 (en) * | 1999-08-27 | 2006-07-20 | Sugen, Inc., South San Francisco | Phosphate mimetics and methods of treatment with phosphatase inhibitors HIBITORS |
-
2007
- 2007-06-27 CN CN2007800309846A patent/CN101506180B/en active Active
-
2009
- 2009-01-21 ZA ZA200900492A patent/ZA200900492B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101506180A (en) | 2009-08-12 |
CN101506180B (en) | 2013-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3323815T3 (en) | Human Protein Tyrosine Phosphatase Inhibitors and Methods of Use | |
IL196129A0 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
ZA200900558B (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
EP1812012A4 (en) | Protein tyrosine phosphatase inhibitors and methods of use thereof | |
IL262205A (en) | Protein formulations and methods of making same | |
EP2021455A4 (en) | Cytoblock preparation system and methods of use | |
ZA200704888B (en) | Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases | |
EP2068898A4 (en) | Bone cement and methods of use thereof | |
IL193473A0 (en) | Amide derivatives and their application for the treatment of g protein related diseases | |
EP1981888A4 (en) | Inhibitors of tyrosine kinases and uses thereof | |
EP2091588A4 (en) | Cardiac device and methods of use thereof | |
EP2046413A4 (en) | Medical systems and methods of use | |
EP1991231A4 (en) | Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases | |
IL197501A0 (en) | Modifications of cupredoxin derived peptides and methods of use thereof | |
ZA200902419B (en) | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases | |
EP2139337A4 (en) | Inhibitors of fibroblast activation protein, and methods of use thereof | |
EP1877424A4 (en) | Inhibitors of protein kinases and uses thereof | |
IL206891A0 (en) | Therapeutic inhibitors of pai-1 function and methods of their use | |
EP1802737A4 (en) | Tissue system and methods of use | |
ZA200900492B (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
EP2045245A4 (en) | Inreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof | |
EP2265117A4 (en) | Inhibitors of protein phosphatase-1 and uses thereof | |
IL198079A0 (en) | Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |